GREENFIELD, Ind., Oct. 28, 2015 /PRNewswire/ -- Elanco Animal Health has launched Interceptor® Plus (milbemycin oxime/praziquantel) in the United States. Interceptor Plus is a monthly chewable tablet that prevents heartworm disease caused by Dirofilaria immitis and protects against intestinal parasites including adult hookworm (Ancylostoma caninum), adult roundworm (Toxocara canis, Toxascaris leonina), adult whipworm (Trichuris vulpis) and adult tapeworm (Taenia pisiformis, Echinococcus multilocularis and Echinococcus granulosus) in dogs.
Interceptor Plus is chicken flavored, making it a good choice for dogs with beef allergies. Dosing is easy, with more than 96% overall acceptability. It is safe for use in dogs and puppies 6 weeks of age and older that weigh 2 pounds or more.
"Interceptor Plus is a great choice for dog owners with active, outdoor dogs," according to Dr. Stephen Connell, Director, Technical, Academic and Consumer Services. "Dogs that play in dog parks or frequently visit boarding or grooming facilities where they interact with other dogs also can benefit from Interceptor Plus."
Interceptor Plus is approved by the FDA and available only through veterinarians. The product is supported by an Elanco product guarantee. "This is another product that supports Elanco's commitment to helping pets live longer, healthier, higher-quality lives," Connell said.
Elanco, a division of Eli Lilly and Company, provides comprehensive products and knowledge services to improve animal health and food-animal production in more than 70 countries around the world. With a global presence of approximately 7,000 people and offices in more than 40 countries, Elanco anticipates, serves and supports the diverse and evolving needs of its customers — from veterinarians to food producers to all those concerned with animal health — to help them address the challenges of a diverse and changing world. Together with our customers, we are committed to raising awareness about global food security and celebrating and supporting the human-animal bond. Additional information about Elanco is available at www.elanco.com or follow us @Elanco.
Important Safety Information
Treatment with fewer than 6 monthly doses after the last exposure to mosquitoes may not provide complete heartworm prevention. Prior to administration of Interceptor Plus, dogs should be tested for existing heartworm infections. The safety of Interceptor Plus has not been evaluated in dogs used for breeding or in lactating females. The following adverse reactions have been reported in dogs after administration of milbemycin oxime or praziquantel: vomiting, diarrhea, depression/lethargy, ataxia, weight loss, convulsions, weakness, and salivation. Please see full product information below.
Interceptor, Elanco and the diagonal bar are trademarks owned by or licensed to Eli Lilly and Company, its affiliates or subsidiaries.
© Eli Lilly and Company, its affiliates or subsidiaries. USCAHINP00019
| Contact: |
Christina Gaines, Elanco, 317-276-3845 |
| Sharon Polk, McCormick Company, 816-584-8444 |
Photo - http://photos.prnewswire.com/prnh/20151028/281483-INFO
SOURCE Elanco Animal Health
Share this article